Renovarp
Payments companies reported to CMS as associated with Renovarp. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Renovarp, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Renovarp
These are the largest totals companies reported as associated with Renovarp. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lee Coryell | Pottstown, PA | Vascular & Interventional Radiology | $81.61 |
| Ravi Pavurala | Galveston, TX | Gastroenterology (Internal Medicine) | $75.58 |
| Victoria Archibald | Fort Worth, TX | Physician Assistant | $75.57 |
| Melvin Simien | Fort Worth, TX | Gastroenterology (Internal Medicine) | $68.88 |
| Howard Stein | Arlington, TX | Gastroenterology (Internal Medicine) | $67.25 |
| Karen Kindler | Fort Worth, TX | Physician Assistant | $54.88 |
| Shivang Mehta | Fort Worth, TX | Transplant Hepatology | $54.88 |
| Saraswathi Saiprasad | Fort Worth, TX | Endocrinology, Diabetes & Metabolism | $54.88 |
| Apurva Modi | Rockville, MD | Gastroenterology (Internal Medicine) | $54.87 |
| Sravanya Gavini | Dallas, TX | Gastroenterology (Internal Medicine) | $42.00 |
Prescribed Renovarp?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.